Advanced Biologic Research in Victoria

With the introduction of biological drugs, the treatment process of rheumatoid arthritis has witnessed a fundamental change. According to the biologic research in Victoria, the biological drugs for RA (rheumatoid arthritis) vary from patient to patient. The ongoing biologic research in Victoria in rheumatoid arthritis is focused in a few areas. They are –

Key Factors of Biologic Research in Victoria:

  1. Epidemiology
  2. Genetics
  3. Drug treatments
  4. Immunology and biology
  5. Complementary and alternative therapies
  6. Impact of rheumatoid arthritis on people and society

In the recent years, several types of biologic research on biology and immunology have advanced our understanding of the factors that are involved in the progression of damage to joints and the activation of the immune system and the other structures in rheumatoid arthritis. This research continues to offer new insights into the complex interaction between the chemicals and antigens and the immune system cells.

In the management of rheumatoid arthritis, other biologic research efforts in Victoria are focusing on the complementary and alternative medicine (CAM) treatments. A broad range of interventions including herbal, vitamin, minerals and other supplements, alternative system of medicine (TCM or Traditional Chinese Medicine, Acupuncture), exercise and mind body interventions (yoga, meditation, Tai Chi). A highly qualified fibromyalgia doctor in Victoria can actively involve in biologic research in rheumatoid arthritis.


Clinical Research – Extensive experience in multiple clinical trials with new Biologics. At present, there are on-going clinical trials in Ankylosing Spondylitis, Spondyloarthropathy,Psoriatic arthritis, and Rheumatoid arthritis. These help to lead the way top improved patient care for now and in future.
Patients who qualify for these trials will be able to access new Biologics without cost for these expensive treatments that may not qualify for pharmacare coverage for various reasons.

    The present enrolling studies underway include:
  1. Certiluzimab for Spondyloarthropathy
  2. Stelara for Ankylosing Spondylitis
  3. Humira and Tofacitinib for Rheumatoid arthritis
  4. Secukinumab for Psoriatic arthritis

Degenerative Arthritis

Osteoarthritis therapy with attention to biomechanics,Intra articular injections with steroids, visco supplementation.

Inflammatory Arthritis

Aggressive DMARD therapy when indicated.For inflammatory arthritis of any kind.

Cutting Edge Treatments

Extensive experience in Biologic therapy,Infusions, sub - cutaneous injections and oral.